Twin Health

Get the latest jobs and industry news

We’re excited to share that the Validation Institute has completed a new, independent review of Twin Health’s AI Digital Twin program reaffirming our ability to deliver both clinical transformation and meaningful financial value. The Institute validated more than $10,000 in annualized cost-of-care avoidance per participant, driven by: • $𝟰,𝟳𝟮𝟬 in directly observed pharmacy savings from reduced reliance on GLP-1s and other high-cost medications • $𝟱,𝟰𝟭𝟯 in modeled medical cost savings, tied to clinically validated improvements in A1C and BMI • Rapid deprescription benefits delivered within the first 3–6 months, accelerating ROI for employers Twin is one of the few solutions to demonstrate RCT-verified savings alongside credible long-term medical cost reductions. This is the kind of rigor, transparency, and real-world impact employers and health plans can trust. Read the full report: https://lnkd.in/eiGbRVrP

Healthcare for people with type 2 diabetes, prediabetes, and obesity has been reactive, fragmented, and one-size-fits-all. Twin is redefining what is possible by creating a new category of continuous, precision metabolic care — tailored to each individual, powered by AI Digital Twin technology and proactive human support. The results of a randomized controlled trial published in NEJM Catalyst speak for themselves: 💊 85% of Twin participants eliminated GLP-1s 💙 71% of Twin participants normalized A1C without high-cost medications, compared to just 2.4% of people in the control group 📉 Twin participants lost an average of 27 lbs and kept the weight off after discontinuing medications Hear perspectives 🎬 𝗟𝗶𝘃𝗲 𝗳𝗿𝗼𝗺 𝗖𝗹𝗲𝘃𝗲𝗹𝗮𝗻𝗱, 𝗢𝗵𝗶𝗼: 💙 Deb, a Twin user from the clinical trial 💙 Jahangir Mohammed, Founder and CEO of Twin 💙 Dr. Lisa Shah, Executive Vice President and Chief Medical Officer of Twin 💙 Dr. Bree Willis, Medical Director of Twin “This is the way of the future.”

In honor of National Diabetes Month, CBS News featured the results of our landmark clinical trial published in the New England Journal of Medicine Catalyst. The AI Digital Twin, supported by our compassionate care team, represents a new standard of care for diabetes and weight loss. Dr. Kevin Pantalone, the lead study author, shares more about the results of the trial as a breakthrough in metabolic healthcare. ⬇️ #NationalDiabetesMonth CBS Mornings

Imagine how it feels to take control of type 2 diabetes while reducing the medications you take. An independent randomized controlled trial, published in the New England Journal of Medicine Catalyst, demonstrates that our Twin Precision Treatment platform helps members: 💙 Normalize their A1C 💙 Lose weight 💙 Safely eliminate high-cost medications

🎬 𝗟𝗶𝘃𝗲 𝗳𝗿𝗼𝗺 𝗖𝗹𝗲𝘃𝗲𝗹𝗮𝗻𝗱, 𝗢𝗵𝗶𝗼: In a new video series, our coaches, members, and leaders share how Twin Health is defining a new standard of care for people with type 2 diabetes, prediabetes, and obesity. Carolyn is a registered dietician with decades of experience. She joined the Twin Health care team 4 years ago to provide better care to people struggling to maintain their metabolic health. With our AI Digital Twin, Carolyn is empowered with a real-time understanding of each member’s unique metabolism and can provide in-the-moment coaching that works for each member's biology and behavior. Learn more about partnering with Twin: https://lnkd.in/ezT9VxVE